Inventor · disambiguated record
Weifeng Huang
Also filed as: HUANG WEIFENG · HUANG WEIFENG JOANNE
5 granted patents·11 pending applications·0 citations·filing 2018–2025
59Inventor score
Top patents by PatentIndex Score
16 records- 0160US2025297034A1Anti-vegf-anti-pd-l1 bispecific antibody, pharmaceutical composition of same, and uses thereofBIOTHEUS INC·Filed 2025·Application pending·0 cites
- 0259US12325759B2Anti-VEGF-anti-PD-L1 bispecific antibody, pharmaceutical composition of same, and uses thereofBIOTHEUS INC·Filed 2021·Granted Jun 10, 2025·0 cites·34 claims
- 0356US2025122296A1Bispecific antibody and use thereofBIOTHEUS INC·Filed 2022·Application pending·0 cites
- 0454US12409233B2Anti-PD-L1 single-domain antibody and derivatives and use thereofBIOTHEUS INC·Filed 2020·Granted Sep 9, 2025·0 cites·10 claims
- 0553US2025223353A1Anti-pvrig antibody, pharmaceutical composition thereof and use thereofBIOTHEUS INC·Filed 2023·Application pending·0 cites
- 0653US2025223354A1Anti-tigit-anti-pvrig bispecific antibody, pharmaceutical composition thereof and use thereofBIOTHEUS INC·Filed 2023·Application pending·0 cites
- 0752US2025297009A1Anti-pd-1 monoclonal antibody, derivative thereof and use thereofBIOTHEUS INC·Filed 2023·Application pending·0 cites
- 0852US2025092050A11-aminobenzo[4,5]imidazo[1,2-a]pyrazine-3-formamide compound, and preparation therefor and use thereofUNIV SUN YAT SEN·Filed 2022·Application pending·0 cites
- 0951US11708417B2Miniaturized antibody of anti-glucocorticoid-induced tumor necrosis factor receptor (GITR), and polymer and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2019·Granted Jul 25, 2023·0 cites·25 claims
- 1049US2023348627A1Anti-4-1bb-anti-pd-l1 bispecific antibody, and pharmaceutical composition and use thereofBIOTHEUS INC·Filed 2021·Application pending·0 cites
- 1148US2025345451A1Anti-pd-l1 single-domain antibody and derivatives and use thereofBIOTHEUS INC·Filed 2025·Application pending·0 cites
- 1247US11655296B2Anti-CD47 antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2019·Granted May 23, 2023·0 cites·19 claims
- 1347US11498972B2Anti-OX40 antibody and use thereofINNOVENT BIOLOGICS SUZHOU CO LTD·Filed 2018·Granted Nov 15, 2022·0 cites·24 claims
- 1447US2025019436A1Bispecific Antibody against TIGIT and PD-L1, and Pharmaceutical Composition Thereof and Use ThereofBIOTHEUS INC·Filed 2022·Application pending·0 cites
- 1547US2024352118A1Anti-tigit antibody and use thereofBIOTHEUS INC·Filed 2022·Application pending·0 cites
- 1644US2022331416A1Combined expression of a chimeric cd3 fusion protein and an anti-cd3-based bispecific t cell activating elementBIOTHEUS SUZHOU CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Weifeng Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →